Effect of chromium (VI) exposure on antioxidant defense status and trace element homeostasis in acute experiment in rat

Abstract

Occupational exposure to hexavalent chromium (Cr(VI)) compounds is of concern in many Cr-related industries and their surrounding environment. Cr(VI) is a proven toxin and carcinogen. The Cr(VI) compounds are easily absorbed, can diffuse across cell membranes, and have strong oxidative potential. Despite intensive studies of Cr(VI) pro-oxidative effects, limited data exist on the influence of Cr(VI) on selenoenzymes thioredoxin reductase (TrxR) and glutathione peroxidase (GPx)—important components of antioxidant defense system. This study investigates the effect of Cr(VI) exposure on antioxidant defense status, with focus on these selenoenzymes, and on trace element homeostasis in an acute experiment in rat. Male Wistar rats (130–140g) were assigned to two groups of 8 animals: I. control; and II. Cr(VI) treated. The animals in Cr(VI) group were administered a single dose of K₂Cr₂O₇ (20 mg /kg, intraperitoneally (ip)). The control group received saline solution. After 24 h, the animals were sacrificed and the liver and kidneys were examined for lipid peroxidation (LP; thiobarbituric acid reactive substances (TBARS) concentration), the level of reduced glutathione (GSH) and the activities of GPx-1, TrxR-1, and glutathione reductase (GR). Samples of tissues were also used to estimate Cr accumulation and alterations in zinc, copper, and iron levels. The acute Cr(VI) exposure caused an increase in both hepatic and renal LP (by 70%, p < 0.01 and by 15%, p < 0.05, respectively), increased hepatic GSH level and GPx-1 activity, and decreased renal GPx-1 activity. The activity of GR was not changed. A significant inhibitory effect of Cr(VI) was found on TrxR-1 activity in both the liver and the kidneys. The ability of Cr(VI) to cause TrxR inhibition could contribute to its cytotoxic effects. Further investigation of oxidative responses in different in vivo models may enable the development of strategies to protect against Cr(VI) oxidative damage.

Keywords

Hexavalent chromium oxidative stress antioxidant defense selenoenzymes trace elements

Get full access to this article

View all access options for this article.

References

Alexander

Aaseth

(1995) Uptake of chromate in human red blood cells and isolated rat liver cells: the role of the anion carrier. Analyst 120: 931–933.

Anand

(2005a) Protective effect of vitamin B6 in chromium-induced oxidative stress in liver. Journal of Applied Toxicology 25: 440–443.

Anand

(2005b) Pyridoxine attenuates chromium-induced oxidative stress in rat kidney. Basic and Clinical Pharmacology and Toxicology 97: 58–60.

Arivarasu

Fatima

Mahmood

(2008) Oral administration of potassium dichromate inhibits brush border membrane enzymes and alters anti-oxidant status of rat intestine. Archives of Toxicology 82: 951–958.

Bagchi

Stohs

(2001) Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene. Molecular and Cellular Biochemistry 222: 149–158.

Bagchi

Stohs

Downs

Bagchi

Preuss

(2002) Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180: 5–22.

Boşgelmez

Güvendik

(2004) Effects of taurine on oxidative stress parameters and chromium levels altered by acute hexavalent chromium exposure in mice kidney tissue. Biological Trace Element Research 102: 209–225.

Boşgelmez

Söylemezoğlu

Güvendik

(2008) The protective and antidotal effects of taurine on hexavalent chromium-induced oxidative stress in mice liver tissue. Biological Trace Element Research 125: 46–58.

Chmielnicka

Swietlicka

Nasiadek

(2002) Essential elements as early indicators of hexavalent chromium nephrotoxicity. Ecotoxicology and Environmental Safety 53: 20–26.

10.

Costa

(1997) Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Critical Reviews in Toxicology 27: 431–442.

11.

Cupo

Wetterhahn

(1985) Modification of chromium(VI)-induced DNA damage by glutathione and cytochromes P-450 in chicken embryo hepatocytes. Proceedings of the National Academy of Science United States of America 82: 6755–6759.

12.

Eybl

Kotyzová

Bludovská

(2004) The effect of curcumin on cadmium-induced oxidative damage and trace elements level in the liver of rats and mice. Toxicology Letters 151: 79–85.

13.

Fatima

Mahmood

(2007) Vitamin C attenuates potassium dichromate-induced nephrotoxicity and alterations in renal brush border membrane enzymes and phosphate transport in rats. Clinica Chimica Acta 386: 94–99.

14.

Gibb

Lees

Pinsky

Rooney

(2000) Lung cancer among workers in chromium chemical production. American Journal of Industrial Medicine 38: 115–126.

15.

Günzler

Kremers

Flohe

(1974) An improved coupled test procedure for glutathione peroxidase (EC 1.11.1.9.) in blood. Zeitschrift für Klinische Chemie und Klinische Biochemie 12: 444–448.

16.

Hojo

Satomi

(1991) In vivo nephrotoxicity induced in mice by chromium(VI). Involvement of glutathione and chromium(V). Biological Trace Element Research 31: 21–31.

17.

Holmes

Wise

Sr (2008) Carcinogenicity of hexavalent chromium. Indian Journal of Medical Research 128: 353–372.

18.

Holmgren

Bjornstedt

(1995) Thioredoxin and thioredoxin reductase. Methods in Enzymology 252: 199–208.

19.

Holmgren

(2010) Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochemistry Biophysics Research Communications 396: 120–124.

20.

Kasprzak

(2002) Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis. Free Radical in Biology and Medicine 31: 958–967.

21.

Katz

Salem

(1993) The toxicology of chromium with respect to its chemical speciation: a review. Journal of Applied Toxicology 13: 217–224.

22.

Limón-Pacheco

Gonsebatt

(2009) The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutation Research 674: 137–147.

23.

Liu

Husler

Leonard

Cutler

Chen

. (2001) On the mechanism of Cr(VI)-induced carcinogenesis: dose dependence of uptake and cellular responses. Molecular and Cellular Biochemistry 222: 221–229.

24.

Liu

Shi

(2001) In vivo reduction of chromium (VI) and its related free radical generation. Molecular and Cellular Biochemistry 222: 41–47.

25.

Mihara

Uchiyama

(1978) Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry 86: 271–278.

26.

Myers

Antholine

Myers

(2008) Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells. Toxicology 246: 222–233.

27.

Myers

(2009) The effects of hexavalent chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells. Free Radical in Biology and Medicine 47: 1477–1485.

28.

Nordberg

Arnér

(2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical in Biology and Medicine 31: 1287–1312.

29.

Occupational Safety and Health Administration (OSHA) (2010) Revising the notification requirements in the exposure determination; provisions of the hexavalent chromium standards. OSHA Federal Register 75: 12485–12409.

30.

Parveen

Khan

Siddiqui

(2009) Pycnogenol prevents potassium dichromate K2Cr2O7-induced oxidative damage and nephrotoxicity in rats. Chemico-Biological Interactions 181: 343–350.

31.

Patlolla

Barnes

Yedjou

Velma

Tchounwou

(2009) Oxidative stress, DNA damage, and antioxidant enzyme activity induced by hexavalent chromium in Sprague-Dawley rats. Environmental Toxicology 24: 66–73.

32.

Pellerin

Booker

(2000) Reflections on hexavalent chromium: health hazards of an industrial heavyweight. Environmental Health Perspectives 108: A402–A407.

33.

Salnikow

Zhitkovich

(2008) Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chemical Research in Toxicology 21: 28–44.

34.

Sasame

Boyd

(1978) Paradoxical effects of cobaltous chloride and salts of other divalent metals on tissue levels of reduced glutathione and microsomal mixed-function oxidase components. Journal of Pharmacology and Experimental Therapeutics 205: 718–724.

35.

Sedlak

Lindsay

(1968) Estimation of total, proteinbound and nonprotein sulfhydryl groups in tissue with Ellman‘s reagent. Analytical Biochemistry 25: 192–205.

36.

Shi

Dalal

(1990) On the hydroxyl radical formation in the reaction between hydrogen peroxide and biologically generated chromium(V) species. Archives of Biochemistry and Biophysics 277: 342–350.

37.

Shi

Chiu

Chen

Halliwell

Castranova

Vallyathan

(1999) Reduction of chromium(VI) and its relationship to carcinogenesis. Journal of Toxicology and Environmental Health, Part B: Critical Reviews 2: 87–104.

38.

Smith

Vierheller

Thorne

(1988) Assay of glutathione reductase in crude tissue homogenates using 5,5′-dithiobis(2-nitrobenzoic acid) Analytical Biochemistry 175: 408–413.

39.

Standeven

Wetterhahn

(1991) Possible role of glutathione in chromium(VI) metabolism and toxicity in rats. Pharmacology and Toxicology 68: 469–476.

40.

Tandon

Behari

Kachru

(1979) Distribution of chromium in poisoned rats. Toxicology 13: 29–34.

41.

von Burg

Liu

(1993) Chromium and hexavalent chromium. Journal of Applied Toxicology 13: 225–230.

42.

Wang

Xing

Shen

Zhu

(2006) Oral administration of Cr(VI) induced oxidative stress, DNA damage and apoptotic cell death in mice. Toxicology 228: 16–23.